Outlook Therapeutics, Inc. - Common Stock (NQ:OTLK)

0.5133 -0.0060 (-1.16%)

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Outlook Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Shares of Outlook Therapeutics Rose Tuesday ↗

June 06, 2023

The healthcare stock hit a 52-week high for the second consecutive day.

Via The Motley Fool

Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 06, 2023

Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.

Via Benzinga

Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter ↗

June 06, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Analyst Expectations for Outlook Therapeutics's Future ↗

April 03, 2023

Via Benzinga

Earnings Outlook For Outlook Therapeutics ↗

December 26, 2022

Via Benzinga

Outlook Therapeutics Shares Pop After Filing US Application For Its Lead Eye Disease Candidate ↗

August 30, 2022

Via Benzinga

Why Microvast Holdings Shares Are Trading Lower By Around 22%; Here Are 20 Stocks Moving Premarket ↗

May 23, 2023

Gainers Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after posting better-than-expected quarterly sales.

Via Benzinga

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 22, 2023

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

Via Benzinga

Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 24, 2023

Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.

Via Benzinga

Super Micro Computer, Garrett Motion, Rackspace Technology And Other Big Stocks Moving Lower On Monday ↗

April 24, 2023

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 50 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023 ↗

April 03, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023 ↗

February 06, 2023

Via Benzinga

JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th

January 11, 2023

Via ACCESSWIRE

What's Next For Stocks After S&P 500 Wraps Roughest Year Since 2008? ↗

December 30, 2022

The SPDR S&P 500 ETF Trust (NYSE: SPY) 500 declined for the fourth consecutive week as the stock market completed its worst year in more than a decade.

Via Benzinga

Earnings Scheduled For December 27, 2022 ↗

December 27, 2022

Companies Reporting Before The Bell • Outlook Therapeutics (NASDAQ:OTLK) is expected to report earnings for its fourth quarter. This article was generated by Benzinga's automated content engine and...

Via Benzinga

Can The Economy Weather Inflation, A Winter Storm, Elon Musk? ↗

December 23, 2022

The S&P 500 traded lower for the third consecutive week on concerns inflation may be more stubborn than anticipated.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 15, 2022

Via Benzinga

TRACON Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Aggressively Buying ↗

October 06, 2022

US gold futures traded slightly higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022 ↗

October 31, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 27, 2022

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.

Via Benzinga

A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says ↗

September 13, 2022

Chardan initiated coverage on Outlook Therapeutics Inc (NASDAQ: OTLK) with a Buy rati

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022 ↗

September 13, 2022

Upgrades See all analyst ratings upgrades.

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 30, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 08, 2022

Via Benzinga

82 Biggest Movers From Yesterday ↗

June 15, 2022

Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday.

Via Benzinga

62 Biggest Movers From Yesterday ↗

June 02, 2022

Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday.

Via Benzinga

44 Stocks Moving In Wednesday's Mid-Day Session ↗

June 01, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 01, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 01, 2022

Good morning, investors! Busy traders are already at work this morning as we go over the biggest pre-market stock movers for Wednesday.

Via InvestorPlace

18 Stocks Moving in Wednesday's Pre-Market Session ↗

June 01, 2022

Gainers Endo International plc (NASDAQ: ENDP) rose 46.1% to $0.7710 in pre-market trading after gaining over 12% on Tuesday.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.